Previous 10 | Next 10 |
home / stock / cmndf / cmndf news
Picture1 TORONTO, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ( CSE: CMND, FSE: CWY0 , OTCMKTS: CMNDF ) (“ Clearmind ” or the " Company "), a psychedelic medicine biotech company focused on the discovery and development of novel psychedeli...
A renowned speaker, and bestselling author, Dr. Gabor Maté is highly sought after for his expertise on a range of topics including addiction, stress and childhood development TORONTO, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ( CSE: CMND, FSE: CWY0 , OTC Pin...
Clearmind Medicine (CSE: CMND) (FSE: CWY0) (OTC: CMNDF) , a psychedelic drug company, has announced the third webinar in its Psychedelics for Alcoholism series. During this webinar, addiction specialist and world-renowned author Dr. Gabor Maté will talk on the effects of...
TORONTO, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ( CSE: CMND, FSE: CWY0 , OTC Pink: CMNDF ) (“ Clearmind ” or the " Company "), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived th...
Clearmind’s Management Team Will Explain the Regulatory Process Required for Clearmind’s Patented MEAI Molecule to Become an FDA Approved Medicine for Treating Alcohol Use Disorder and Binge Drinking TORONTO, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ( ...
The CPA's Panel for physicians and medical professionals addressed "New Psychedelic Substances" TORONTO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ( CSE: CMND, FSE: CWY0 , OTC Pink: CMNDF ) (“ Clearmind ” or the " Company "), a psych...
TORONTO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ( CSE: CMND, FSE: CWY0 , OTC Pink: CMNDF ) (“ Clearmind ” or the " Company "), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived th...
TORONTO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ( CSE: CMND, FSE: CWY0 , OTC Pink: CMNDF ) (“ Clearmind ” or the “ Company ”), a psychedelic medicine biotech company focused on the discovery and development of novel psychede...
F ocus on the discovery and development of novel therapeutic strategies to treat obesity and its related metabolic disorders TORONTO, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTC Pink: CMNDF ), (“ Clearmind ” or t...
Toronto, Ontario, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTC Pink: CMNDF ), (“ Clearmind ” or the " Company "), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derive...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq and CSE: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated h...
The first episode, "Psychedelic Novelty - Before it was Cool," introduces the company's proprietary molecule MEAI VANCOUVER, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND), (OTC Pink: CMNDF), (FSE: CWY0) (“ Clearmind ” or the " company ...
VANCOUVER, Sept. 25, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND), (OTC Pink: CMNDF), (FSE: CWY0) (“ Clearmind ” or the " Company "), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertr...